INTRODUCTION
============

Human telomerase is a ribonucleoprotein complex composed of a telomerase catalytic subunit (hTERT) and an RNA component (hTR) that adds hexameric repeats to the end of chromosomes ([@b5-molce-41-7-684]). In human somatic cells, telomerase activity is strongly suppressed and progressive shortening of telomeres with age leads to cellular senescence and apoptotic cell death ([@b54-molce-41-7-684]). However, some highly proliferative cells, such as germline and stem cells, exhibit stable telomere length through maintenance of telomerase expression and activity ([@b29-molce-41-7-684]). High telomerase activity in somatic cells, associated with cell cycle deregulation, may be important for cancer initiation and progression ([@b6-molce-41-7-684]; [@b32-molce-41-7-684]). In approximately 90% of cancers, telomerase is re-expressed and accounts for telomere maintenance ([@b29-molce-41-7-684]), suggesting that inhibition of telomerase may be an attractive anti-cancer strategy.

Accumulating evidence demonstrates that hTERT promotes cellular and organismal survival, independent of telomere lengthening---the canonical function of hTERT. We previously reported that hTERT has a protective effect against staurosporine- (STS) ([@b33-molce-41-7-684]) or N-methyl-D-aspartic acid (NMDA)-induced cell death ([@b28-molce-41-7-684]; [@b33-molce-41-7-684]). Using mouse telomerase reverse transcriptase (mTERT) transgenic mice lacking mouse telomerase RNA component (mTR) expression, we demonstrated that the anti-apoptotic effect of hTERT is unrelated to its known enzymatic activity *in vivo* ([@b33-molce-41-7-684]). Several independent groups also demonstrated the ability of hTERT to promote cellular survival in response to apoptotic stimuli ([@b8-molce-41-7-684]; [@b40-molce-41-7-684]; [@b45-molce-41-7-684]; [@b65-molce-41-7-684]). Additionally, MYC can regulate apoptosis and TERT can regulate MYC-dependent oncogenesis independently of its telomerase activity *in vivo* ([@b30-molce-41-7-684]); however, the precise mechanisms remain unclear. It has been suggested that the anti-apoptotic effect of hTERT is related to inhibition of the intrinsic apoptosis pathway upon apoptotic stimuli ([@b16-molce-41-7-684]; [@b33-molce-41-7-684]; [@b40-molce-41-7-684]; [@b65-molce-41-7-684]); however, a convincing direct link between hTERT and the intrinsic apoptosis pathway has not yet been demonstrated.

Proteins of the BCL-2 family play a critical role in regulating the mitochondrial pathway of intrinsic apoptosis by controlling mitochondrial outer membrane permeabilization (MOMP) ([@b10-molce-41-7-684]). Members of the BCL-2 family can be divided into three functional groups, antiapoptotic proteins, pro-apoptotic effectors, and BH3-only proteins ([@b20-molce-41-7-684]). They contain at least one of four conserved BCL-2 homology (BH) domains designated BH1, BH2, BH3, and BH4, which correspond to alpha-helical segments ([@b46-molce-41-7-684]). The multidomain proapoptotic effectors, BAX or BAK, are required for mitochondrial apoptosis initiation, resulting in the release of cytochrome c from mitochondria. However, the anti-apoptotic proteins of the BCL-2 family directly bind to pro-apoptotic effectors and tightly regulate the balance between cellular life and death decisions. BH3-only proteins, which contain a single BH3 motif, can directly activate pro-apoptotic proteins (BAX and BAK) or inhibit anti-apoptotic proteins (BCL-2, BCL-xL, MCL-1, and BCL-w) by competitively disrupting the interaction between pro-apoptotic effectors and antiapoptotic proteins ([@b20-molce-41-7-684]). Importantly, identification of a novel BH-only protein, AVEN, by bioinformatics and computational biology suggests the existence of a distinct subclass of a functional BH3-only protein as an apoptosis inhibitor which interacts and stabilizes BCL-xL ([@b22-molce-41-7-684]).

In this report, we identified a BH3-like motif within the telomerase essential N-terminal (TEN) domain of hTERT. Since the BH3 motif is an amphipathic alpha-helix that is present in both pro- and anti-apoptotic proteins and binds to the hydrophobic grooves of anti-apoptotic proteins ([@b31-molce-41-7-684]; [@b42-molce-41-7-684]), we found that hTERT can interact with anti-apoptotic BCL-2 proteins MCL-1 and BCL-xL. Furthermore, we explored whether the BH3-like motif of hTERT can affect interactions between hTERT and anti-apoptotic protein MCL-1. A mutagenesis study revealed that hTERT interacts with anti-apoptotic protein MCL-1, through both BH3-dependent and independent mechanisms. Thus, the non-canonical interaction between hTERT and anti-apoptotic proteins may regulate hTERT protective effects in contrast to typical BH3-only proteins which induce cellular apoptosis. Besides, we showed that hTERT does not modulate the interactions of BCL-xL/BAX complex, frequently involved in the death-promoting function of BH3-only proteins. Although we could not determine the physiological outputs and pathological effects of the interaction between hTERT and BCL-2 family proteins, we suggest that hTERT is a novel BH3-containing protein which belongs to the atypical subclass of a BH3-like motif and interacts with BCL-2 family members.

MATERIALS AND METHODS
=====================

Cell lines and culture
----------------------

HEK 293T/17, U2OS, and HeLa cells were obtained from the American Type Culture Collection (ATCC). Cells were grown in dishes until confluency and then trypsinized, washed, and resuspended in high-glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin, and 100 μg/ml streptomycin (Gibco). Cells were incubated at 37°C and 5% CO~2~ in a humidified incubator.

Plasmid construction
--------------------

pCMV-hBCL-2 plasmid was obtained from the Korea Human Gene Bank (KHGB). To generate expression plasmids for N-terminal 3× FLAG-tagged, 3× MYC-tagged, or 3× HA-tagged proteins, the full-length coding sequence of target proteins was amplified from cDNA by PCR using the Herculase II Fusion DNA Polymerase (Agilent Technologies). PCR products were digested with engineered *Eco*RI and *Xba*I sites and the resulting PCR fragments were cloned into 3× FLAG-pCS4, 3× MYC-pCS4, or 3× HA-pCS4 vectors. All cloned constructs were confirmed by DNA sequencing.

Telomeric repeat amplification protocol assay
---------------------------------------------

TRAP assay was performed as described previously ([@b33-molce-41-7-684]) with slight modifications. In brief, U2OS cells were transiently co-transfected with pBS-TER (hTR) and the indicated plasmids using Lipofectamine 3000 (Thermo Fisher Scientific) according to manufacturer's instructions. Cells were then lysed in CHAPS buffer for 30 min on ice. After centrifugation (14,000 × g for 20 min at 4°C), the resulting supernatant was subjected to a TRAP reaction with a TS primer (5′-AATCCGTCGAGCAGAGTT-3′). The TRAP reaction was performed at 25°C for 30 min, followed by PCR amplification. PCR was performed with the TS and CX (5′-GCGCGGCTTACCCTTACCCTTACCCTAACC-3′) primer, using the following conditions: 95°C for 30 s, 52°C for 30 s, 72°C for 30 s, for 28 cycles. The resulting PCR products were resolved on a 12.5% nondenaturing acrylamide gel and stained with the silver staining method.

Co-immunoprecipitation assay
----------------------------

HEK 293T/17 cells seeded on 100-mm plates were transiently transfected with the indicated expression plasmids using the polyethylenimine (PEI) transfection method ([@b35-molce-41-7-684]). One day following transfection (24 h), the cells were harvested for co-immunoprecipitation assays. Briefly, the cells were washed once with phosphate buffered saline and lysed in 1 ml of lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 0.5% Triton X-100, 1 mM EDTA, and protease cocktail inhibitor) or immunoprecipitation-TRAP lysis buffer (10 mM Tris pH 7.4, 1 mM MgCl~2~, 1 mM EDTA, 0.5% NP-40, 10% Glycerol, 5 mM β-Mercaptoethanol, and protease cocktail inhibitor). An aliquot of each cell lysate was subjected to SDS-PAGE for determining protein expression by western blot analysis. The remaining lysates were subjected to immunoprecipitation. Lysates were incubated with 1 μg of indicated antibodies for 2 h and then mixed with 30 μl of a 50% slurry of protein G-agarose (Invitrogen) for a further 2 h at 4°C. In the case of FLAG immunoprecipitation, anti-FLAG antibodies bound to protein G magnetic beads (Sigma Aldrich) were added to the remaining lysates for 3 h at 4°C. The beads were washed twice with lysis buffer and resuspended in 2× SDS sample buffer. The resulting products were resolved by SDS-PAGE. For TRAP assay, the beads were recovered by immunoprecipitation-TRAP lysis buffer after washing steps and then subjected to a TRAP reaction.

Western blotting and antibodies
-------------------------------

Western blotting was performed as described previously ([@b62-molce-41-7-684]) with slight modifications. Cell pellets were resuspended in lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 0.5% Triton X-100, 1mM EDTA pH 8.0, and protease cocktail inhibitor). Soluble extracts were prepared by centrifugation (14,000 × g for 20 min at 4°C). Cell lysates were separated by 6--15% SDS-PAGE and then transferred to nitrocellulose membranes (GE Healthcare). Membranes were blocked for 1 h with 3% dried skim milk in TBST (50 mM Tris pH 8.0, 150 mM NaCl, and 0.5% Tween 20) and incubated with the following primary antibodies, anti-HA (Santa Cruz, sc-805), anti-FLAG (Sigma Aldrich, F1804), anti-MYC (Cell Signaling, \#2276), anti-BCL-xL (Cell Signaling, \#2764), anti-MCL-1 (Santa Cruz, sc-819), anti-ACTIN (Santa Cruz, sc-47778), anti-GAPDH (Santa Cruz, sc-32233), anti-BCL2 (Santa Cruz, sc-7382), anti-BAX (Santa Cruz, sc-493), and anti-PARP1 (Santa Cruz, sc-7150). After incubation with primary antibodies, the membranes were incubated with the appropriate peroxidase-conjugated secondary antibodies (GeneDEPOT, USA). Protein expression was detected by enhanced chemiluminescence (ECL) reagents and LAS-3000 image analyzer (Fujifilm, Japan).

Immunocytochemistry
-------------------

For fluorescence microscopy, Transfected HEK293T/17 cells were grown on cover slips in 12-well plates. The cells were fixed with 4% paraformaldehyde for 15 min at room temperature, washed with PBS twice, permeabilized with 0.5% Triton X-100 in PBS for 15 min, and then blocked in 5% bovine serum albumin for 30 min. All samples were incubated with indicated antibodies in blocking buffer for 2 h and followed by the secondary antibody for 1 h at room temperature. The samples were mounted with fluorescence mounting medium containing DAPI (Abcam, ab104139) and observed by LSM 880 Zeiss confocal microscope (Zeiss).

RESULTS
=======

To investigate how hTERT can regulate cellular apoptosis through a telomere length-independent mechanism, we first contemplated previous findings on the protective effects of hTERT against apoptotic stimuli. Of those, several papers suggested that anti-apoptotic function of hTERT might be related to the mitochondrial death pathway ([@b16-molce-41-7-684]; [@b33-molce-41-7-684]; [@b40-molce-41-7-684]; [@b65-molce-41-7-684]). It was also observed that overexpression of hTERT suppresses BCL-2-dependent apoptosis ([@b16-molce-41-7-684]). Based on reported evidence, we decided to investigate the role of hTERT at the mitochondrial level.

hTERT contains a BH3-like motif in the N-terminal region
--------------------------------------------------------

We first analyzed the primary sequence of hTERT to determine its subcellular localization or specific protein-protein interactions. This analysis led us to the identification of a BH3-like motif, a short peptide sequence found in the BCL-2 protein family. Although the BH3 sequence has not been rigorously confirmed due to its divergent evolution ([@b3-molce-41-7-684]), it is commonly defined by a sequence identity of L-X(3)-G-D (X designates any amino acid) ([@b3-molce-41-7-684]; [@b4-molce-41-7-684]) or by conserved hydrophobic residues responsible for contact with interaction pockets ([@b11-molce-41-7-684]; [@b15-molce-41-7-684]; [@b23-molce-41-7-684]; [@b59-molce-41-7-684]). Using these criteria, we identified a BH3-like region at residues 133--156 within the hTERT N-terminal sharing a highly conserved sequence with MCL-1 BH3 ([Fig. 1A](#f1-molce-41-7-684){ref-type="fig"}). The existence of a BH3 motif suggests that this region of hTERT may be important for interaction with BCL-2 family proteins. To identify if the hTERT BH3-like motif is conserved among species, we compared phylogenetic homology sequences starting from *Saccharomyces cerevisiae* to humans. Interestingly, alignment of the hTERT BH3-like motif between species revealed that this sequence is well-conserved from *Xenopus laevis* to humans ([Fig. 1B](#f1-molce-41-7-684){ref-type="fig"}). Similar to the hTERT BH3-like motif, the N-terminal mitochondrial targeting sequence was found to be conserved in higher eukaryotes, such as plants and mammals ([@b49-molce-41-7-684]). Thus, the N-terminus of hTERT may contain evolutionarily significant regions for mitochondrial functions.

Protein secondary structure prediction of the hTERT Nterminal region---based on *Tetrahymena thermophile* crystal structures and JPred3 software ([@b13-molce-41-7-684])---revealed that a region corresponding to the putative BH3 motif of humans might form an alpha-helix ([@b27-molce-41-7-684]; [@b51-molce-41-7-684]). A helical wheel diagram of the hTERT BH3-like motif (amino acids 137--152) illustrated that there are five conserved hydrophobic sites composed of W137, L141, V144, V148, and L152, as well as a conserved oppositely charged residue (D146) similar to that of the BH3-only protein, BIM ([Fig. 1C](#f1-molce-41-7-684){ref-type="fig"}). Conserved hydrophobic residues of the amphipathic helix of BH3-only proteins bind to hydrophobic pockets in the surface groove of anti-apoptotic BCL-2 proteins ([@b11-molce-41-7-684]; [@b23-molce-41-7-684]), while the Asp residue forms a salt bridge with the conserved Arg residue of the BH1 domain of pro-survival proteins ([@b15-molce-41-7-684]). These results suggest that hTERT contains a BH3-like motif satisfying the minimum requirements for an interaction with BH3-binding grooves of anti-apoptotic proteins.

hTERT interacts with anti-apoptotic proteins BCL-xL and MCL-1
-------------------------------------------------------------

Based on the identification of the BH3 motif in hTERT, we hypothesized that hTERT might be able to interact with BCL-2 family members. To assess this hypothesis, we first performed a co-immunoprecipitation (co-IP) assay with hTERT and anti-apoptotic BCL-2 proteins. Previous reports suggested that the BH3 motif of BH3-only proteins mostly interact with anti-apoptotic BCL-2 proteins ([@b52-molce-41-7-684]). HEK 293T/17 cells were transiently transfected with tagged-constructs of wild-type (WT) hTERT and either BCL-xL or MCL-1. As expected, co-IP assay revealed that hTERT interacts with anti-apoptotic BCL-xL and MCL-1 ([Fig. 2A](#f2-molce-41-7-684){ref-type="fig"}). A reciprocal co-IP assay also confirmed that hTERT can be found in BCL-xL and MCL-1 precipitates ([Fig. 2B](#f2-molce-41-7-684){ref-type="fig"}). hTERT was apparently co-localized with MCL-1 in HEK 293T/17 cells ([Supplementary Fig. S1A](#s1-molce-41-7-684){ref-type="supplementary-material"}). Additionally, we detected telomerase activity from the cell extracts subjected to immunoprecipitation with endogenous MCL-1 and BCL-xL antibodies ([Supplementary Fig. S1B](#s1-molce-41-7-684){ref-type="supplementary-material"}), indicating that hTERT can endogenously associate with anti-apoptotic BCL-2 proteins in living cells.

We next determined the requirement of the hTERT BH3-like motif in mediating hTERT-MCL-1 interactions. After generating truncated hTERT constructs corresponding to the TEN domain (amino acids 1--355), TERT RNA binding domain (TRBD, amino acids 320--604), reverse transcriptase domain (RT, amino acids 595--946), and C-terminal extension domain (CTE, amino acids 940--1132), we performed domain mapping analyses ([Fig. 1A](#f1-molce-41-7-684){ref-type="fig"}). Mapping analyses for hTERT interaction domains with the MCL-1 protein indicated that hTERT fragments of both amino acids 1--355 and 595--946 contribute to MCL-1 interactions, corresponding to the TEN and RT domains of hTERT, respectively ([Fig. 2C](#f2-molce-41-7-684){ref-type="fig"}). To further characterize the interaction between hTERT and MCL-1, a series of hTERT BH3 mutants were created. The conserved Leu, Gly, and Asp residues of BH3-only proteins were previously reported as critical for interactions with antiapoptotic proteins ([@b14-molce-41-7-684]; [@b38-molce-41-7-684]; [@b64-molce-41-7-684]). Consistent with previous data, each amino acid substitution mutation of the hTERT BH3-like motif weakened its interaction with MCL-1, although it did not completely abrogate the interaction ([Fig. 2D](#f2-molce-41-7-684){ref-type="fig"}). Similar results were obtained when the experiments were repeated with a deletion mutant that lacks amino acids 137--148 of the BH3-like motif (data not shown). In line with their binding abilities to MCL-1, hTERT also interacted with BCL-xL through both TEN and RT domains ([Supplementary Fig. S1C](#s1-molce-41-7-684){ref-type="supplementary-material"}). Taken together, the results suggest that hTERT can interact with the anti-apoptotic protein MCL-1 through both BH3-dependent and independent mechanisms.

hTERT binds to BH3-only proteins BAD and BECN, but not to pro-apoptotic proteins
--------------------------------------------------------------------------------

We next examined whether hTERT interacts with BH3-only proteins or multidomain pro-apoptotic proteins. Despite sharing BH3 motif sequence homology, some BH3-only proteins can selectively bind to pro-apoptotic proteins or other BH3-only proteins ([@b12-molce-41-7-684]; [@b47-molce-41-7-684]; [@b56-molce-41-7-684]). The interaction between hTERT and BH3-only proteins or pro-apoptotic proteins was validated by co-IP analysis. Notably, we observed that hTERT was co-precipitated with BH3-only proteins BAD and BECN1 ([Figs. 3A and 3B](#f3-molce-41-7-684){ref-type="fig"}), suggesting that hTERT might interact with various BCL-2 family members. To further examine the BECN1 region responsible for interactions with hTERT, we generated constructs expressing BECN1 domains. BECN1 is reported to consist of three domains, the BH3 domain (amino acids 1--140), coiled-coil domain (amino acids 141--277), and evolutionarily conserved domain (amino acids 245--450) ([@b60-molce-41-7-684]). In particular, we found that hTERT binds to the coiled-coil domain of BECN1, which serves as an interaction platform for Atg14L or UVRAG to regulate autophagy ([Fig. 3C](#f3-molce-41-7-684){ref-type="fig"}) ([@b41-molce-41-7-684]). Interestingly, binding of hTERT and pro-apoptotic members BAK or BAX was not detected in our conditions (data not shown).

Telomerase activity is not associated with anti-apoptotic proteins BCL-xL and MCL-1
-----------------------------------------------------------------------------------

Based on the above data, it appears that hTERT can transiently interact with BCL-xL or MCL-1 and that the BH3-like motif is conserved in higher eukaryotes. The TEN domain of hTERT, containing the putative BH3 motif, is known to be important in the catalysis of telomeric repeat addition ([@b27-molce-41-7-684]; [@b55-molce-41-7-684]). Previous analysis of yeast TERT (Est2p) N-terminal region suggested that point mutations of residues corresponding to the BH3-like motif of hTERT exhibit low or undetectable levels of telomerase activity and shortening of telomeres, leading to yeast senescence ([@b61-molce-41-7-684]). However, the significance of BH3-like motif residues and function has not yet been investigated in higher eukaryotes. Therefore, we tested if the BH3-like motif is important for telomerase activity. The MCL-1 binding-defective hTERT mutants (L141A, G145E, and D146A) can directly address the effect of BH3-dependent interactions between hTERT and MCL-1 on telomerase activity. We transfected telomerase-negative U2OS cells with hTERT BH3 mutants and examined telomerase activity by telomeric repeated amplification protocol (TRAP) assays. Unexpectedly, among the hTERT BH3 mutants tested, only the deletion mutant that lacks amino acids 137--148 of the BH3-like motif resulted in severe reduction of telomerase activity ([Fig. 4A](#f4-molce-41-7-684){ref-type="fig"}). The substitution mutants (L141A, G145E, and D146A) showed a marginal effect on telomerase activity, inconsistent with previous data from yeast TERT ([@b61-molce-41-7-684]). These results imply that the BH3-like residues 137--148 likely maintain telomerase activity regardless of MCL-1 association.

In cancer cells, stable overexpression of anti-apoptotic BCL-2 has been shown to increase telomerase activity ([@b39-molce-41-7-684]). Moreover, we observed that the RT domain of hTERT contributes to its interactions with BCL-xL and MCL-1. To examine the relationship between telomerase activity and the BCL-2 family proteins, HeLa and HEK 293T/17 cells were transiently transfected with BCL-xL or MCL-1 constructs. After 48 h, cell lysates were analyzed by TRAP assays to detect telomerase activity. We did not observe any significant changes in telomerase activity after ectopic expression of BCL-xL and MCL-1 ([Fig. 4B](#f4-molce-41-7-684){ref-type="fig"}, [Supplementary Fig. S2](#s1-molce-41-7-684){ref-type="supplementary-material"}); therefore, we concluded that their transient expression does not regulate telomerase activity in cancer cells.

hTERT does not stabilize STS-induced MCL-1 downregulation
---------------------------------------------------------

We previously demonstrated that hTERT protects cellular apoptosis upon STS treatment regardless of telomere elongation activity and suggested that this observed protective effect of hTERT may be a consequence of mitochondrial death pathway suppression ([@b33-molce-41-7-684]). The observed interaction between hTERT and BCL-2 family members led us to hypothesize that the protective effect of hTERT in response to apoptotic stimuli might arise from regulation of BCL-2 family members. The stability of anti-apoptotic proteins has been described as a relevant step for anti-apoptotic potency ([@b48-molce-41-7-684]); therefore, we first examined the change in BCL-2 family protein levels upon STS treatment. As shown in [Fig. 5A](#f5-molce-41-7-684){ref-type="fig"}, STS significantly decreased protein levels of MCL-1, a key regulator of apoptosis, after 4 h of treatment as previously reported ([@b25-molce-41-7-684]); however, BCL-xL and BAX protein levels were not profoundly changed. MCL-1 is required to be eliminated for apoptosis to proceed and the protein has a short half-life that is unique among BCL-2 family members ([@b25-molce-41-7-684]; [@b43-molce-41-7-684]). In addition, we also confirmed that decreased level of MCL-1 is dependent on both transcriptional and translational regulations following STS treatment ([Figs. 5B and 5C](#f5-molce-41-7-684){ref-type="fig"}). To determine if the protective effect of hTERT is related to MCL-1 degradation, we transfected HEK 293T/17 cells with hTERT and observed MCL-1 protein turnover upon STS treatment. Overexpression of hTERT did not affect MCL-1 protein levels ([Fig. 5D](#f5-molce-41-7-684){ref-type="fig"}), indicating that hTERT inhibits STS-induced apoptosis mainly through a different action mechanism, beyond MCL-1 stabilization.

hTERT does not directly modulate cellular survival by regulating the BCL-xL/BAX complex
---------------------------------------------------------------------------------------

Recent studies showed that BCL-xL inhibits BAX-dependent apoptosis by constant retro-translocation of BAX from the mitochondria into the cytosol ([@b17-molce-41-7-684]). Since STS treatment also induces cellular apoptosis by promoting translocation of BAX to the mitochondria ([@b34-molce-41-7-684]), we tested if overexpression of hTERT affects BCL-xL and BAX interaction. Additionally, the presence of an hTERT BH-like motif provoked interest since this short peptide motif can act as a death signal by displacing BAX/BCL-xL heterodimers ([@b10-molce-41-7-684]; [@b11-molce-41-7-684]). HEK 293T/17 cells were transfected with FLAG-tagged BCL-xL and MYC-tagged hTERT, followed by co-IP of endogenous BAX under different detergent conditions. It is known that various detergents can alter BAX conformation, inducing the exposure of the N-terminal epitope ([@b17-molce-41-7-684]; [@b24-molce-41-7-684]), which is required for BCL-xL interaction in the mitochondria ([@b17-molce-41-7-684]). We found that hTERT does not alter the BAX/BCL-xL ratio in the presence of either Triton X-100 or CHAPS ([Fig. 6A](#f6-molce-41-7-684){ref-type="fig"}). The BH3-only protein BAD can form a heterodimer with BCL-xL, triggering apoptosis in a BAX-dependent manner by displacing BAX/BCL-xL heterodimers ([@b63-molce-41-7-684]); therefore, we next examined if hTERT indirectly regulates BAX/BCL-xL heterodimers through BAD, which also transiently interacts with hTERT ([Fig. 3A](#f3-molce-41-7-684){ref-type="fig"}). Although ectopic expression of HA-tagged BAD can abolish the interaction between endogenous BAX and FLAG-tagged BCL-xL, we did not detect significant changes in BAX/BCL-xL heterodimers ratios ([Fig. 6B](#f6-molce-41-7-684){ref-type="fig"}). Additionally, we did not observe an obvious difference in BAK/MCL-1 heterodimers after hTERT overexpression ([Fig. 6C](#f6-molce-41-7-684){ref-type="fig"}). These results suggest that hTERT does not directly modulate cellular survival through mediation of BAX/BCL-xL or BAK/MCL-1 complex interactions. Nevertheless, we cannot preclude the possibility that hTERT regulates its anti-apoptotic function by regulating other BCL-2 members or by controlling other MCL-1 or BCL-xL functions related to cellular survival ([@b44-molce-41-7-684]).

We further investigated if hTERT can alter BECN1/BCL-xL interactions, similar to other BH3-only proteins. BH3-only proteins can regulate autophagy by disrupting the BECN1/BCL-xL complex ([@b37-molce-41-7-684]). Additionally, it was recently shown that telomerase activates autophagy mediated by mTOR signaling under acute kidney injury ([@b21-molce-41-7-684]). However, the BECN1/BCL-xL complex interaction was not affected by hTERT expression ([Fig. 6D](#f6-molce-41-7-684){ref-type="fig"}). The data suggest that hTERT may regulate the BECN1 complex through the coiled-coil domain and not the BH3 domain ([Fig 4C](#f4-molce-41-7-684){ref-type="fig"}). Although we do not possess clear evidence regarding the effects of hTERT and BCL-2 family protein interactions on autophagy and apoptosis, we suggest that hTERT contains a BH3-like motif that contributes to interact with MCL-1 and BCL-xL and acts as an atypical BH3-only protein that promotes cellular survival.

DISCUSSION
==========

Human telomerase reverse transcriptase (hTERT) is a 127-kDa protein with four domains and several evolutionarily conserved motifs. Although several groups have reported non-canonical functions of hTERT, searching for novel non-telomeric motifs within the conserved domain has been mostly overlooked. In the present study, we report that hTERT has a BH3-like motif within the TEN domain of the Nterminal region. It was previously demonstrated that hTERT is translocated from the nucleus to the mitochondria following oxidative stress or chemical treatments ([@b1-molce-41-7-684]; [@b18-molce-41-7-684]; [@b19-molce-41-7-684]; [@b65-molce-41-7-684]). This finding led to the discovery of a protective role for hTERT in mitochondria ([@b1-molce-41-7-684]; [@b18-molce-41-7-684]; [@b19-molce-41-7-684]; [@b40-molce-41-7-684]) and it was shown that hTERT has a mitochondrial targeting sequence in its N-terminal region ([@b49-molce-41-7-684]). Additionally, mitochondrial TERT interacts with the RNA component of mitochondrial RNA processing endoribonuclease (RMRP) to regulate RNA-dependent RNA polymerase (RdRP) activity ([@b36-molce-41-7-684]) or act as an hTR-independent reverse transcriptase in mitochondria ([@b53-molce-41-7-684]). Since nuclear exclusion of hTERT plays a critical role in apoptosis, senescence, and mitochondrial function ([@b1-molce-41-7-684]; [@b50-molce-41-7-684]), the identification of a BH3-like motif supports the notion that hTERT may be strongly associated with the intrinsic apoptotic pathway or mitochondrial functions.

We previously reported an anti-apoptotic effect of TERT *in vivo* using mTERT transgenic mice and mTR knockout mice ([@b33-molce-41-7-684]). Moreover, several papers have suggested that the anti-apoptotic function of hTERT might depend on the BCL-2 family. hTERT overexpression inhibits translocation of BAX to the mitochondria upon oxidative stress ([@b26-molce-41-7-684]) and BCL-2-dependent apoptosis ([@b16-molce-41-7-684]), independently of telomerase activity. Furthermore, depletion of hTERT sensitized cellular apoptosis by decreasing expression levels of anti-apoptotic protein BCL-2 ([@b58-molce-41-7-684]) and facilitating the activation of pro-apoptotic protein BAX via conformational changes ([@b40-molce-41-7-684]). However, finding that hTERT possesses a putative BH3 binding motif was unexpected. Since the BH3 motif is known to regulate intrinsic apoptosis through BCL-2 family interactions, the existence of a BH3-like motif in hTERT provides biological evidence linking it to BCL-2 family-mediated functions. We showed that hTERT can interact with antiapoptotic proteins MCL-1 or BCL-xL in a BH3-dependent or independent manner. Since hTERT promotes cellular survival through BAX- or BCL-2-dependent mechanisms ([@b16-molce-41-7-684]; [@b26-molce-41-7-684]; [@b40-molce-41-7-684]), we examined if hTERT can regulate BAX/BCL-xL or BAK/MCL-1 heterodimer formation; however, these complexes were unaffected by ectopic hTERT expression.

Our findings also raise questions regarding the exact role of the BH3 motif in apoptotic cell death. Unlike most BH3-containing proteins that activate or sensitize cell death ([@b42-molce-41-7-684]), hTERT is an anti-apoptotic protein. Thus, the discovery of a BH3-like motif has drawn our attention to the inconsistencies in results regarding the role of BH3-only proteins in triggering cell death. Most BH3-containing proteins were previously identified by L-X(3)-G-D sequence motif along with their pro-apoptotic functions. Recently, however, a few BH3-containing proteins were characterized as apoptosis inhibitors after they were reported as BCL-xL interaction partners ([@b22-molce-41-7-684]; [@b57-molce-41-7-684]). BECN1 was also identified as an atypical BH3-only protein that fails to induce apoptosis and was first isolated as a BCL-2 binding protein ([@b7-molce-41-7-684]). To resolve inconsistent findings, Aouacheria and colleagues ([@b4-molce-41-7-684]) introduced the concept that the BH3 motif is a novel class of short linear motifs (SLiMs) involved in protein-protein interactions and not proapoptotic functions. Although hTERT also contains a BH3-like motif, this motif may weakly interact with anti-apoptotic proteins and thereby constrain their pro-apoptotic activity. Overall, hTERT behaves as an atypical BH3-only protein that does not induce apoptosis.

The precise mechanism by which hTERT exerts its non-canonical function in promoting cellular and organismal survival is still enigmatic. However, it is important to note that hTERT has a non-telomeric conserved sequence motif that mediates protein interactions. Transient protein-protein interactions of hTERT, which are not involved in telomere maintenance, may play key roles in many aspects of cellular physiology. Recently, it was revealed that telomerase can regulate autophagy through the mTOR signaling pathway ([@b2-molce-41-7-684]; [@b9-molce-41-7-684]). Additionally, we found that hTERT interacts with BECN1, a BH3-only protein, through a coiled-coil domain important for autophagy induction, suggesting that hTERT may also regulate autophagy through BECN1 interactions. Thus, multiple non-canonical functions of hTERT are likely to be associated with BCL-2 family members and mediated by protein-protein interactions. Identification of direct associations between BCL-2 family proteins and hTERT may aid in understanding the roles of hTERT in novel non-canonical functions, thereby contributing to elucidate the molecular mechanisms of its physiology and pathology.
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![An hTERT BH3-like motif within the N-terminal region\
(A) Sequence alignment of the hTERT BH3-like motif with other BH3 domains of BCL-2 family proteins. Schematic representation of hTERT domains presented at the top. The BH3-like motif is localized in the TEN domain. Conserved hydrophobic residues are marked by asterisks. Characteristics of the amino acids are highlighted in different colors. Red, hydrophobic residues; green, small residues; blue, acidic residues; magenta, basic residues. The putative BH3 sequence is Φ~1~-Sm-X-X-Φ~2~(L)-K/R-R-Φ~3~-G-D-D/E-Φ~4~-X-X-X-Φ~5~. Φ, hydrophobic residues; Sm, small residues; X, random amino acids. (B) Sequence homology and phylogenetic analysis from *Saccharomyces cerevisiae* to humans. (C) Helical wheel plots of the putative BH3 sequence between BIM and hTERT. Hydrophobic and charged residues are indicated by blue and red, respectively. A cluster of hydrophobic residues are depicted by the yellow line.](molce-41-7-684f1){#f1-molce-41-7-684}

![Interactions between hTERT and anti-apoptotic proteins BCL-xL and MCL-1\
(A) Co-immunoprecipitation (co-IP) analysis of hTERT and BCL-xL or MCL-1. HEK 293T/17 cells were transfected with the indicated plasmids, followed by co-IP analysis of ectopically expressed hTERT and BCL-xL or MCL-1. (B) Reciprocal co-IP analysis of hTERT and BCL-xL or MCL-1 interactions. The asterisk indicates a nonspecific band. (C) Domain mapping of the interaction between hTERT and MCL-1. HEK 293T/17 cells were transfected with the indicated hTERT truncation mutants, followed by co-IP and Western blot analysis with the indicated antibodies. Mapping of the hTERT domain revealed that both TEN and RT domains are important for MCL-1 interaction. The asterisk indicates a nonspecific band. (D) Co-IP of MCL-1 and hTERT BH3 mutants. hTERT BH3 mutants (L141A, G145E, and D146A) were generated by point mutations at key residues of the BH3 core motif. The hTERT BH3 mutants did not fully disrupt interactions with MCL-1.](molce-41-7-684f2){#f2-molce-41-7-684}

![hTERT interactions with BH3-only proteins BAD and BECN1\
(A, B) Co-IP of hTERT and BAD or BECN1. hTERT can bind to BH3-only proteins BAD and BECN1. (C) Domain mapping of the interaction between hTERT and BECN1. A schematic representation of BECN1 domains is shown at the top. HEK 293T/17 cells were transfected with the indicated plasmids, followed by co-IP assays with anti-FLAG beads. The indicated antibodies were used to detect bound proteins eluted from the beads. The coiled-coil domain of BECN1 is important for hTERT interaction. CCD, coiled-coil domain; ECD, evolutionarily conserved domain.](molce-41-7-684f3){#f3-molce-41-7-684}

![Correlation between telomerase activity and anti-apoptotic proteins BCL-xL and MCL-1\
(A) Effects of hTERT BH3 mutants on telomerase activity. Telomerase-negative U2OS cells were transiently transfected with expression plasmids encoding FLAG-tagged wild-type (WT) of hTERT, MCL-1 binding-defective mutants (L141A, G145E, D146A), or an hTERT BH3 deletion mutant. Telomerase activity was detected by TRAP assay. IC, internal control of the TRAP assay; NC, negative control without telomerase extract. (B) Telomerase activity by anti-apoptotic proteins BCL-xL and MCL-1 using TRAP analysis. HeLa cells were transiently transfected with the indicated constructs. Transient expression of antiapoptotic BCL-2 members did not affect telomerase activity.](molce-41-7-684f4){#f4-molce-41-7-684}

![Effects of STS-induced MCL-1 downregulation by hTERT\
(A) Staurosporine (STS) treatment for the indicated time points downregulated MCL-1 expression. Western blot analysis was performed for MCL-1, BCL-xL, and BAX protein expression over a 6-h time course following treatment with STS. After 4 h of treatment, STS significantly decreased protein levels of MCL-1 but not BCL-xL or BAX. (B) Quantitative reverse transcription PCR (qRT-PCR) analysis of MCL-1 during STS treatment. (C) Effects of the proteasome inhibitor MG132 on MCL-1 degradation. (D) Western blot analysis of hTERT-expressing HEK 293T/17 cells after STS treatment. There were no significant changes in MCL-1 protein levels by hTERT overexpression.](molce-41-7-684f5){#f5-molce-41-7-684}

![Modulation of BCL-2 family protein complexes by hTERT\
(A) Co-IP of BAX and BCL-xL in hTERT-overexpressing HEK 293T/17 cells. Cells were co-transfected with FLAG-BCL-xL and MYC-hTERT, and then lysed in either Triton X-100 or CHAPS buffer. FLAG-BCL-xL was immunoprecipitated with anti-FLAG beads, followed by western blot analysis with the indicated antibodies. No significant differences in BAX/BCL-xL ratios were observed after hTERT overexpression. (B) Co-IP of BAX and BCL-xL with BAD and hTERT overexpression. The cells were lysed with detergent containing Triton X-100. BAD can disrupt BAX/BCL-xL heterodimers, but hTERT did not affect the BAD-dependent BAX/BCL-xL complex ratios. (C) Co-IP experiment of BAK and MCL-1 with hTERT overexpression. (D) Co-IP analysis of BCL-xL and BECN1 with hTERT overexpression. The BECN1/BCL-xL interaction is not altered by hTERT overexpression.](molce-41-7-684f6){#f6-molce-41-7-684}
